Effects of exogenous surfactant on gas exchange and compliance in rabbits after meconium aspiration
- PMID: 11802248
- DOI: 10.1002/ppul.10056
Effects of exogenous surfactant on gas exchange and compliance in rabbits after meconium aspiration
Abstract
Success in using adjunctive surfactant therapy for meconium aspiration has been inconsistent. We tested the hypothesis that the ability of exogenous surfactant to improve gas exchange and pulmonary compliance after meconium aspiration is related to the method of surfactant administration. In anesthetized rabbits (2.4 +/- 0.16 kg body weight), an endotracheal tube (ETT) was placed in the lower trachea, and the lungs were ventilated mechanically. After a control period, filtered meconium (3-5 mL/kg) was instilled through the ETT. Group 1 (n = 5) was not given surfactant. Thirty minutes after meconium instillation, group 2 (n = 5) was given a bolus of bovine surfactant (Beractant, 4 mL/kg) through the ETT, and group 3 (n = 5) was given an infusion of Beractant (4 mL/kg for 1 hr) through the side-port of the ETT. Thirty minutes after meconium instillation, tracheal pressure increased by 8 +/- 1 cm H(2)O (mean +/- SEM), dynamic compliance decreased by 0.36 +/- 0.07 mL/cm H(2)O/kg, arterial PO(2) (PaO(2)) decreased by 49 +/- 6.0 mmHg, arterial PCO(2) (PaCO(2)) increased by 12 +/- 2.4 mmHg, and arterial pH (pHa) decreased by 0.09 +/- 0.02. After 3 hr of exposure to meconium, tracheal pressure was significantly (P < 0.001) lower in group 3 compared to groups 1 or 2. PaO(2) remained below baseline in all groups. Group 3 had a significantly (P = 0.001) higher dynamic compliance than groups 1 or 2. Likewise, static compliance was higher for group 3 compared to groups 1 or 2, with the greatest difference at low lung volume. Mean arterial blood pressure, pulse rate, PaCO(2), and pHa were not significantly different between groups. These results suggest that continuous infusion of exogenous surfactant is more effective than bolus administration in improving pulmonary function after meconium aspiration.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
-
Surfactant therapy for meconium aspiration syndrome: current status.Drugs. 2005;65(18):2569-91. doi: 10.2165/00003495-200565180-00003. Drugs. 2005. PMID: 16392874 Review.
-
Different doses of exogenous surfactant for treatment of meconium aspiration syndrome in newborn rabbits.Rev Hosp Clin Fac Med Sao Paulo. 2004 Jun;59(3):104-12. doi: 10.1590/s0041-87812004000300003. Epub 2004 Jul 28. Rev Hosp Clin Fac Med Sao Paulo. 2004. PMID: 15286829
-
Exogenous surfactant improves lung compliance and oxygenation in adult rats with meconium aspiration.J Appl Physiol (1985). 1994 Oct;77(4):1961-71. doi: 10.1152/jappl.1994.77.4.1961. J Appl Physiol (1985). 1994. PMID: 7836224
-
Effects of a recombinant surfactant protein-C-based surfactant on lung function and the pulmonary surfactant system in a model of meconium aspiration syndrome.Crit Care Med. 2006 Jan;34(1):203-10. doi: 10.1097/01.ccm.0000190624.77908.e2. Crit Care Med. 2006. PMID: 16374175
-
How to overcome surfactant dysfunction in meconium aspiration syndrome?Respir Physiol Neurobiol. 2013 Jun 1;187(1):58-63. doi: 10.1016/j.resp.2013.02.030. Epub 2013 Mar 5. Respir Physiol Neurobiol. 2013. PMID: 23473924 Review.
Cited by
-
Recombinant Human Superoxide Dismutase and N-Acetylcysteine Addition to Exogenous Surfactant in the Treatment of Meconium Aspiration Syndrome.Molecules. 2019 Mar 5;24(5):905. doi: 10.3390/molecules24050905. Molecules. 2019. PMID: 30841517 Free PMC article.
-
Surfactant therapy for meconium aspiration syndrome: current status.Drugs. 2005;65(18):2569-91. doi: 10.2165/00003495-200565180-00003. Drugs. 2005. PMID: 16392874 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources